The Scientist

» work-life balance, immunology and microbiology

Most Recent

image: New Ovarian Cancer Vaccine Shows Promise

New Ovarian Cancer Vaccine Shows Promise

By Catherine Offord | April 12, 2018

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.

1 Comment

image: Some Antibiotics Rev Up Host Immune Response to Viruses

Some Antibiotics Rev Up Host Immune Response to Viruses

By Shawna Williams | April 9, 2018

The antimicrobial drug neomycin protects mice from some viral infections, complicating the picture of the relationship between antibiotics and susceptibility to viruses.

2 Comments

image: Opinion: We Have Been Naive About Naive T Cells

Opinion: We Have Been Naive About Naive T Cells

By Theo van den Broek, José A.M. Borghans, and Femke van Wijk | April 6, 2018

Human naive T cells are far more heterogeneous than has long been appreciated, having implications for vaccine strategies.

2 Comments

image: Ruth Nussenzweig, Malaria Researcher, Dies

Ruth Nussenzweig, Malaria Researcher, Dies

By Jim Daley | April 6, 2018

The microbiologist’s research led to the development of the first human malaria vaccine.

0 Comments

image: Image of the Day: Cell Droplets

Image of the Day: Cell Droplets

By The Scientist Staff | April 4, 2018

Proteins and RNA aggregate into “membraneless organelles” due to liquid-liquid phase separation.

0 Comments

Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.

0 Comments

In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.

0 Comments

Errors in segregation during cell division can lead to inflammation in daughter cells.

0 Comments

The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.

0 Comments

A study finds that the vaccine’s effects wear off as a person ages, suggesting a need for booster shots.

1 Comment

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. “Public” T-Cell Receptors From Resistant People Fend Off HIV